Delivery Order SPE2DB24D9238-SPE2DB24FDQEE
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,016.14 contract is for the supply of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,004.53 firm fixed-price contract is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This contract is not set aside and is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,010.76 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.02 award is for the delivery of 0.7 mg OZURDEX implants. This order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical items to military health facilities worldwide. The...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $2,003.02 contract is for the supply of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $2,003.02 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product. This delivery order is placed against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA, which enables the agency to issue orders for a broad range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,003.02 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product, with a completion date of March 4, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued up to $4,999,999, with the Defense Logistics Agency for the supply of a broad...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, with a potential value of $3,004.53 and a completion date of March 7, 2024. This delivery order is likely part of DMS Pharmaceutical Group's broader indefinite delivery contract with DLA, contract 4600082013 under the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,010.76, is for the delivery of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of OZURDEX 0.7 MG IMPLANTS. The total potential value of the contract is $3,004.53, with a period of performance through April 10, 2024. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Vehicle (IDV) contract, SPE2DB, with the DLA valued at up to $4,999,999 through the end of 2025. This IDV enables the DLA to...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB24FDQEEDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,004.53, is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring pharmaceutical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, that allows the agency to issue delivery orders for a wide range of pharmaceutical items to military medical facilities globally. This contract, which runs through December 31, 2025, complements DMS Pharmaceutical Group's existing prime vendor agreements for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites. The company has a proven track record of supplying an extensive array of branded, generic, and specialty medications to the DoD and Department of Veterans Affairs under various contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 4/18/24 |